The cytokeratin 19 fragment, CYFRA 21.1, is perhaps the most extensively characterised biomarker with diagnostic value for NSCLC (Stieber et al, 1993; Bates et al, 1997; Molina et al, 2003; Tarro et al, 2005). This evidence concerns the gene KRT19 and non-small cell lung carcinoma.